Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer

Daan A.C. Lanser; Niels Heersche; M. Benthe Muntinghe-Wagenaar; Ma Ida Mohmaed Ali; Ezgi B. Ulas; Evert de Jonge; Esther Oomen de Hoop; Marthe S. Paats; Idris Bahce; Sander Croes; Adrianus J. Langen; Lizza E.L. Hendriks; Anthonie J. Wekken; Alwin D.R. Huitema; Ron H.N. Schaik; Anne Marie C. Dingemans; G. D.Marijn Veerman; Ron H.J. Mathijssen

doi:10.34133/cancomm.0031

Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer

Daan A.C. Lanser
, Niels Heersche
, M. Benthe Muntinghe-Wagenaar
, Ma Ida Mohmaed Ali
, Ezgi B. Ulas
, Evert de Jonge
, Esther Oomen de Hoop
, Marthe S. Paats
, Idris Bahce
, Sander Croes
, Adrianus J. Langen
, Lizza E.L. Hendriks
, Anthonie J. Wekken
, Alwin D.R. Huitema
, Ron H.N. Schaik
, Anne Marie C. Dingemans
, G. D.Marijn Veerman
, Ron H.J. Mathijssen

Group Huitema

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	31
Number of pages	1
Journal	Cancer communications (London, England)
Volume	46
DOIs	https://doi.org/10.34133/cancomm.0031
Publication status	Published - 2026

Access to Document

10.34133/cancomm.0031

Cite this

Lanser, D. A. C., Heersche, N., Muntinghe-Wagenaar, M. B., Ali, M. I. M., Ulas, E. B., de Jonge, E., Hoop, E. O. D., Paats, M. S., Bahce, I., Croes, S., Langen, A. J., Hendriks, L. E. L., Wekken, A. J., Huitema, A. D. R., Schaik, R. H. N., Dingemans, A. M. C., Veerman, G. D. M., & Mathijssen, R. H. J. (2026). Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer. Cancer communications (London, England), 46, 31. https://doi.org/10.34133/cancomm.0031

@article{8852cbe5c2ef4c7681fa77a894b8f45f,

title = "Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer",

author = "Lanser, \{Daan A.C.\} and Niels Heersche and Muntinghe-Wagenaar, \{M. Benthe\} and Ali, \{Ma Ida Mohmaed\} and Ulas, \{Ezgi B.\} and \{de Jonge\}, Evert and Hoop, \{Esther Oomen de\} and Paats, \{Marthe S.\} and Idris Bahce and Sander Croes and Langen, \{Adrianus J.\} and Hendriks, \{Lizza E.L.\} and Wekken, \{Anthonie J.\} and Huitema, \{Alwin D.R.\} and Schaik, \{Ron H.N.\} and Dingemans, \{Anne Marie C.\} and Veerman, \{G. D.Marijn\} and Mathijssen, \{Ron H.J.\}",

year = "2026",

doi = "10.34133/cancomm.0031",

language = "English",

volume = "46",

pages = "31",

journal = "Cancer communications (London, England)",

issn = "2523-3548",

publisher = "American Association for the Advancement of Science",

}

Lanser, DAC, Heersche, N, Muntinghe-Wagenaar, MB, Ali, MIM, Ulas, EB, de Jonge, E, Hoop, EOD, Paats, MS, Bahce, I, Croes, S, Langen, AJ, Hendriks, LEL, Wekken, AJ, Huitema, ADR, Schaik, RHN, Dingemans, AMC, Veerman, GDM & Mathijssen, RHJ 2026, 'Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer', Cancer communications (London, England), vol. 46, pp. 31. https://doi.org/10.34133/cancomm.0031

TY - JOUR

T1 - Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer

AU - Lanser, Daan A.C.

AU - Heersche, Niels

AU - Muntinghe-Wagenaar, M. Benthe

AU - Ali, Ma Ida Mohmaed

AU - Ulas, Ezgi B.

AU - de Jonge, Evert

AU - Hoop, Esther Oomen de

AU - Paats, Marthe S.

AU - Bahce, Idris

AU - Croes, Sander

AU - Langen, Adrianus J.

AU - Hendriks, Lizza E.L.

AU - Wekken, Anthonie J.

AU - Huitema, Alwin D.R.

AU - Schaik, Ron H.N.

AU - Dingemans, Anne Marie C.

AU - Veerman, G. D.Marijn

AU - Mathijssen, Ron H.J.

PY - 2026

Y1 - 2026

UR - https://www.scopus.com/pages/publications/105040131388

U2 - 10.34133/cancomm.0031

DO - 10.34133/cancomm.0031

M3 - Letter

C2 - 42179890

AN - SCOPUS:105040131388

SN - 2523-3548

VL - 46

SP - 31

JO - Cancer communications (London, England)

JF - Cancer communications (London, England)

ER -